Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practice.
Journal: American heart journal
Published: March 08, 2026
Clinical Patterns and Appropriateness of Apixaban Dosing in Patients With Atrial Fibrillation.
Journal: JACC. Advances
Published: February 25, 2026
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial.
Journal: JAMA cardiology
Published: March 26, 2025
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Journal: The New England journal of medicine
Published: September 03, 2024
Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: July 31, 2024
Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: November 29, 2023
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
Journal: Journal of the American College of Cardiology
Published: August 16, 2023
Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting.
Journal: Journal of managed care & specialty pharmacy
Published: October 27, 2018
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: July 31, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026